UmbREALung - A Retrospective and Prospective, Observational, Real World Multi-cohort Study of Patients With Non-small Cell Lung Cancer (NSCLC) Initiating Approved Drugs Developed by AZ or as Part of an AZ Alliance
Patients with histologically or cytologically proven NSCLC
Patients initiated with approved drugs developed by AZ or as part of an AZ alliance at the time of the enrollment or within the previous three weeks.
Informed patients who consent to participate in the study as per local regulations.
You may not be if
Patients participating in an interventional clinical trial for NSCLC\*
\* with the exception on low-interventional studies (RIPH2) where the intervention does not involve the NSCLC treatment
Patients already enrolled in another module of the cohort in UMBREALUNG
Patients under safeguard of justice, curatorship or guardianship
Clareo Health | UmbREALung - A Retrospective and Prospective, Observational, Real World Multi-cohort Study of Patients With Non-small Cell Lung Cancer (NSCLC) Initiating Approved Drugs Developed by AZ or as Part of an AZ Alliance
